Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MTUM vs GSK✓SelectedUSD · GSKMTUM vs GSK performance historyLatest closeAs of-5.68%11/20
Stock and ETF performance explorer

MTUM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+256.8%
GSK return
+97.4%
Excess return
+159.4%
Maximum drawdown
-34.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.7%-0.1%-5.6%-5.6%
7D-11.3%-5.3%-6.0%-10.0%
30D-19.5%-3.7%-15.9%-18.8%
3M-20.8%-7.3%-13.6%-19.4%
6M-19.3%-4.2%-15.0%-19.1%
YTD-3.3%+0.9%-4.2%-5.3%
1Y+2.0%+7.3%-5.3%-2.2%
3Y+62.9%+52.7%+10.2%+32.3%
5Y+36.2%+40.1%-3.9%+12.6%
All+256.8%+97.4%+159.4%+151.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling